← FDA Drug Approvals (Drugs@FDA)

ORPHENADRINE CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1982-03-15

Drug application

FDA Application #

ANDA084779

Application type

Abbreviated New Drug Application (Generic)

Brand name

ORPHENADRINE CITRATE

Generic name

ORPHENADRINE CITRATE

Active ingredients

ORPHENADRINE CITRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

WATSON LABS

Manufacturer

Actavis Pharma, Inc.

First approval

1982-03-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown